耳念珠菌驱动的南非念珠菌血症流行病学转变(2016-2017)
南非2016-2017年基于实验室的国家监测纳入269家医院6,669例念珠菌血症病例,其中794例(14%)由耳念珠菌引起。133家医院全念珠菌血症发病风险为83.8例/10万入院(95%CI 81.2-86.4)。耳念珠菌血症院内粗病死率为45%,与非耳念珠菌血症的43%无差异。
要点
- 耳念珠菌占南非念珠菌血症的14%,构成主要流行病学转变。
- 既往全身抗真菌治疗与耳念珠菌血症调整比值比为1.4(95%CI 0.8-2.3)。
- 耳念珠菌血症院内粗病死率45%,与非耳念珠菌血症43%无差异。
核心结论
- 耳念珠菌在南非引起了念珠菌血症的重大流行病学转变。
研究设计与样本
- 基于国家实验室的监测研究,2016-2017年南非269家医院共6,669例念珠菌血症病例,其中5,876例完成菌种鉴定。
主要发现
- 794例(14%)念珠菌血症由耳念珠菌引起。
- 133家医院全念珠菌血症发病风险为83.8例/10万入院(95%CI 81.2-86.4)。
- 既往全身抗真菌药物与耳念珠菌血症调整比值比为1.4(95%CI 0.8-2.3)。
- 耳念珠菌血症院内粗病死率为45%,非耳念珠菌血症为43%,两者无差异。
临床怎么用
- 在耳念珠菌流行地区,对念珠菌血症患者应考虑耳念珠菌可能并加强菌种鉴定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Candida auris is an invasive healthcare-associated fungal pathogen. Cases of candidemia, defined as illness in patients with Candida cultured from blood, were detected through national laboratory-based surveillance in South Africa during 2016-2017. We identified viable isolates by using mass spectrometry and sequencing. Among 6,669 cases (5,876 with species identification) from 269 hospitals, 794 (14%) were caused by C. auris. The incidence risk for all candidemia at 133 hospitals was 83.8 (95% CI 81.2-86.4) cases/100,000 admissions. Prior systemic antifungal drug therapy was associated with a 40% increased adjusted odds of C. auris fungemia compared with bloodstream infection caused by other Candida species (adjusted odds ratio 1.4 [95% CI 0.8-2.3]). The crude in-hospital case-fatality ratio did not differ between Candida species and was 45% for C. auris candidemia, compared with 43% for non-C. auris candidemia. C. auris has caused a major epidemiologic shift in candidemia in South Africa.
引用
- van Schalkwyk E, Mpembe RS, Thomas J, et al. Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-20171. Emerg Infect Dis. 2019. PMID: 31441749. doi:10.3201/eid2509.190040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。